Month: January 2021

2025.07.14
Genomtec has the consent of its shareholders to make a contribution of assets to its subsidiaries in order to accelerate the project sale process

2025.03.26
Genomtec implements changes in organizational structure to accelerate M&A process

2025.03.12
The company will obtain approximately PLN 11 million from the issue to support the commercialization of projects

2025.02.12
Genomtec to issue shares to raise funds to support commercialization of projects

2025.01.28
Genomtec has filed a second patent application for the OncoSNAAT oncology project

Archive

2021.01.20

Genomtec diagnostic test SARS-CoV-2 Duo Kit (cat. no. GA00B) detects all published virus variants (British, South African and Brazilian).

Genomtec conducted a detailed analysis of the introduced in each variant mutations, both by a bioinformatics analysis (in-silico) and also in a ...
Read
2021.01.04

Genomtec ID gets third Prize in the Final of 2020 “Maker in China”

Genomtec’s flagship platform, Genomtec ID, has got a third Prize in the Final of 2020 edition “Maker in China” International SME Innovation & ...
Read

Archive